157 related articles for article (PubMed ID: 31303864)
1. Validation of the Khorana score in acute myeloid leukemia patients: a single-institution experience.
Mirza AS; Yun S; Ali NA; Shin H; O'Neil JL; Elharake M; Schwartz D; Robinson K; Nowell E; Engle G; Badat I; Brimer T; Kuc A; Sequeira A; Mirza S; Sikaria D; Vera JD; Hackney N; Abusrur S; Jesurajan J; Kuang J; Patel S; Khalil S; Bhaskar S; Beard A; Abuelenen T; Ratnasamy K; Visweshwar N; Komrokji R; Jaglal M
Thromb J; 2019; 17():13. PubMed ID: 31303864
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients.
Akasaka-Kihara F; Sueta D; Ishii M; Maki Y; Hirakawa K; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Hanatani S; Kanazawa H; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Soejima H; Kaikita K; Matsushita K; Matsuoka M; Usuku K; Tsujita K
JACC Asia; 2021 Sep; 1(2):259-270. PubMed ID: 36338156
[TBL] [Abstract][Full Text] [Related]
3. Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study.
Martella F; Cerrano M; Di Cuonzo D; Secreto C; Olivi M; Apolito V; D'Ardia S; Frairia C; Giai V; Lanzarone G; Urbino I; Freilone R; Giaccone L; Busca A; Dellacasa CM; Audisio E; Ferrero D; Beggiato E
Ann Hematol; 2022 Apr; 101(4):855-867. PubMed ID: 35128571
[TBL] [Abstract][Full Text] [Related]
4. Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Hepatocellular Carcinoma.
Wang Y; Attar BM; Fuentes HE; Yu J; Zhang H; Tafur AJ
Clin Appl Thromb Hemost; 2018 Apr; 24(3):471-476. PubMed ID: 28288526
[TBL] [Abstract][Full Text] [Related]
5. Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer.
Mansfield AS; Tafur AJ; Wang CE; Kourelis TV; Wysokinska EM; Yang P
J Thromb Haemost; 2016 Sep; 14(9):1773-8. PubMed ID: 27273134
[TBL] [Abstract][Full Text] [Related]
6. Association between the Khorana risk score and all-cause mortality in Japanese patients with gastric and colorectal cancer: A retrospective cohort study.
Zhang YF; Wang GD; Huang MG; Qiu ZQ; Si J; Xu MY
World J Gastrointest Oncol; 2023 Oct; 15(10):1784-1795. PubMed ID: 37969412
[TBL] [Abstract][Full Text] [Related]
7. Using the Khorana risk score to predict venous thromboembolism and overall survival in a cohort of Hispanic patients with solid malignancies.
Ramos-Esquivel A; Marenco-Flores A; Hernández-Romero G; Umaña-Mora C; Céspedes-Calvo A; Mora-Hidalgo R
Ecancermedicalscience; 2022; 16():1470. PubMed ID: 36819798
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the Khorana risk score of gastrointestinal cancer patients during initial chemotherapy as a predictor of patient mortality: A retrospective study.
Shibata K; Tokushige A; Imamura M; Ikeda Y; Ohishi M
J Cardiol; 2022 May; 79(5):655-663. PubMed ID: 34924239
[TBL] [Abstract][Full Text] [Related]
9. The Kagoshima-DVT Score Is a Useful Predictive Model for Cancer-Associated Thrombosis in Patients With Gastrointestinal Cancer.
Shibata K; Tokushige A; Hamamoto Y; Higuchi K; Imamura M; Ikeda Y; Ohishi M
Circ Rep; 2023 Feb; 5(2):19-26. PubMed ID: 36818519
[No Abstract] [Full Text] [Related]
10. Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score.
Rupa-Matysek J; Gil L; Kaźmierczak M; Barańska M; Komarnicki M
Med Oncol; 2017 Dec; 35(1):5. PubMed ID: 29209847
[TBL] [Abstract][Full Text] [Related]
11. OC-10 - Disseminated intravascular coagulation at diagnosis strongly predicts both arterial and venous thrombosis in acute myeloid leukemia patients.
Libourel EJ; Klerk C; van Norden Y; de Maat MP; Kruip MJ; Sonneveld P; Löwenberg B; Leebeek FW
Thromb Res; 2016 Apr; 140 Suppl 1():S172. PubMed ID: 27161682
[TBL] [Abstract][Full Text] [Related]
12. Predictors of active cancer thromboembolic outcomes: mortality associated with calf deep vein thrombosis.
Salazar Adum JP; Diaz Quintero L; Fuentes HE; Lind BB; Caprini JA; Tafur AJ
Int Angiol; 2017 Dec; 36(6):553-557. PubMed ID: 28541021
[TBL] [Abstract][Full Text] [Related]
13. Development of a risk score to predict peripherally inserted central catheter thrombosis in active cancer.
Yuen HLA; Zhao J; Tran H; Chunilal SD
Intern Med J; 2022 Oct; 52(10):1733-1740. PubMed ID: 34613657
[TBL] [Abstract][Full Text] [Related]
14. A Predictive Model for Cancer-Associated Thrombosis in Japanese Cancer Patients: Findings from the J-Khorana Registry.
Shoji M; Yamashita Y; Ishii M; Inoue H; Kato H; Fujita S; Matsui K; Tajiri K; Nameki M; Muraoka N; Nonaka A; Sugino H; Kono M; Oka T; Sueta D; Komuro I; Tsujita K;
TH Open; 2024 Jan; 8(1):e9-e18. PubMed ID: 38197014
[No Abstract] [Full Text] [Related]
15. Predictors of active cancer thromboembolic outcomes. RIETE experience of the Khorana score in cancer-associated thrombosis.
Tafur AJ; Caprini JA; Cote L; Trujillo-Santos J; Del Toro J; Garcia-Bragado F; Tolosa C; Barillari G; Visona A; Monreal M;
Thromb Haemost; 2017 Jun; 117(6):1192-1198. PubMed ID: 28276571
[TBL] [Abstract][Full Text] [Related]
16. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
[TBL] [Abstract][Full Text] [Related]
17. [A long-term follow-up study of 82 children with acute myeloid leukemia].
Ruan M; Qi BQ; Liu F; Liu TF; Liu XM; Chen XJ; Yang WY; Guo Y; Zhang L; Zou Y; Chen YM; Zhu XF
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):730-734. PubMed ID: 30293275
[No Abstract] [Full Text] [Related]
18. Performance of Current Thromboembolism Risk Assessment Tools in Patients With Gastric Cancer and Validity After First Treatment.
Fuentes HE; Paz LH; Wang Y; Oramas DM; Simons CR; Tafur AJ
Clin Appl Thromb Hemost; 2018 Jul; 24(5):790-796. PubMed ID: 28884610
[TBL] [Abstract][Full Text] [Related]
19. A prediction model for central venous catheter-related thrombosis in patients with newly-diagnosed acute myeloid leukemia: A derivation cohort analysis.
Perek S; Khatib A; Izhaki N; Khalaila AS; Brenner B; Horowitz NA
Eur J Intern Med; 2022 Jul; 101():68-75. PubMed ID: 35527180
[TBL] [Abstract][Full Text] [Related]
20. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia.
Gentles AJ; Plevritis SK; Majeti R; Alizadeh AA
JAMA; 2010 Dec; 304(24):2706-15. PubMed ID: 21177505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
